Table 1.
Association between MMP2 expression levels and clinicopathological features in 107 patients with cholangiocarcinoma
| Features | MMP2 Expression | P-value | |
|---|---|---|---|
|
| |||
| Low 48 (%) | High 59 (%) | ||
| Gender | 0.172 | ||
| Male | 29 (60%) | 43 (73%) | |
| Female | 19 (40%) | 16 (27%) | |
| Age (years) | 0.732 | ||
| <55 | 22 (46%) | 29 (49%) | |
| ≥55 | 26 (54%) | 30 (51%) | |
| Differentiation | 0.004 | ||
| Poorly | 9 (19%) | 23 (39%) | |
| Moderately | 33 (69%) | 36 (61%) | |
| Highly | 6 (12%) | 0 (0%) | |
| Vascular invasion | 0.314 | ||
| Yes | 15 (31%) | 24 (41%) | |
| No | 33 (69%) | 35 (59%) | |
| Lymph node metastasis | 0.011 | ||
| Yes | 20 (42%) | 39 (66%) | |
| No | 28 (58%) | 20 (34%) | |
MMP2, Matrix metalloproteinase-2.